Selective Retina Therapy with Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients.
Ye Ji KimYoun Gon LeeDong Won LeeJae Hui KimPublished in: Journal of ophthalmology (2018)
The results of the present study suggest that SRT is a useful therapeutic option for patients with acute idiopathic CSC. Further studies are required to better understand the long-term efficacy of this treatment. This trial is registered with clinical trial registration number NCT03339856.
Keyphrases
- clinical trial
- end stage renal disease
- newly diagnosed
- study protocol
- ejection fraction
- chronic kidney disease
- phase ii
- phase iii
- liver failure
- high grade
- prognostic factors
- randomized controlled trial
- open label
- stem cells
- intensive care unit
- diabetic retinopathy
- bone marrow
- patient reported outcomes
- replacement therapy
- optical coherence tomography
- aortic dissection
- case control
- smoking cessation